Find Ziprasidone Hydrochloride manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

0 DRUGS IN DEVELOPMENT

FDF DossiersDRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

Annual Reports

NA

208 RELATED EXCIPIENT COMPANIES

347EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 122883-93-6, Ziprasidone hcl, Geodon, Zeldox, 5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one hydrochloride, Ziprasidone (hydrochloride)
Molecular Formula
C21H22Cl2N4OS
Molecular Weight
449.4  g/mol
InChI Key
NZDBKBRIBJLNNT-UHFFFAOYSA-N
FDA UNII
JAL53626GG

Ziprasidone Hydrochloride
Ziprasidone Hydrochloride is the hydrochloride salt form of ziprasidone, a benzothiazolylpiperazine derivative and an atypical antipsychotic agent with an antischizophrenic property. Ziprasidone hydrochloride functions as an antagonist at the dopamine D2 and serotonin 5-HT2A and 5-HT1D receptors, and as an agonist at the 5-HT1A receptor. Ziprasidone hydrochloride also inhibits synaptic reuptake of serotonin and norepinephrine. The mechanism of action by which ziprasidone hydrochloride exerts its antischizophrenic effect is unknown but is potentially mediated through a combination of dopamine D2 and serotonin 5-HT2 antagonism. This agent also has antagonistic activity against histamine H1 and alpha-1-adrenergic receptors.
1 2D Structure

Ziprasidone Hydrochloride

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one;hydrochloride
2.1.2 InChI
InChI=1S/C21H21ClN4OS.ClH/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21;/h1-4,11,13H,5-10,12H2,(H,23,27);1H
2.1.3 InChI Key
NZDBKBRIBJLNNT-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54.Cl
2.2 Other Identifiers
2.2.1 UNII
JAL53626GG
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 5-(2-(4-(3-benzisothiazolyl)piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one

2. Cp 88059

3. Cp 88059-01

4. Cp-88,059

5. Cp-88,059-01

6. Cp-88,059-1

7. Geodon

8. Ziprasidone

9. Ziprasidone Hydrochloride, Monohydrate

10. Ziprazidone

2.3.2 Depositor-Supplied Synonyms

1. 122883-93-6

2. Ziprasidone Hcl

3. Geodon

4. Zeldox

5. 5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one Hydrochloride

6. Ziprasidone (hydrochloride)

7. 5-[2-[4-(1,2-benzisothiazol-3yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indol-2-one Hydrochloride

8. Ziprasidone Hydrochloride [usan]

9. Jal53626gg

10. 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indol-2-one Hydrochloride

11. 5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one Hydrochloride

12. Cp 88059 (hydrochloride Monohydrate)

13. 122883-93-6 (hcl)

14. 2h-indol-2-one, 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-, Monohydrochloride

15. 5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-2,3-dihydro-1h-indol-2-one Hydrochloride

16. Cp 88059

17. Ziprasidone Hydrochloride Hydrate

18. C21h21cln4os.hcl

19. Unii-jal53626gg

20. Ziprasidone, Hcl

21. 2h-indol-2-one, 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-, Hydrochloride (1:1)

22. 2h-indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-, Hydrochloride (1:1)

23. Cp-88059 Hydrochloride

24. Chembl1712

25. Mls006010221

26. Schembl122876

27. Dtxsid00153762

28. Hy-14542a

29. S1444

30. Akos015848366

31. Ac-7053

32. Ccg-220561

33. Cs-1887

34. Ks-1219

35. 5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one;hydrochloride

36. Ac-26998

37. Smr002204092

38. Ziprasidone Hydrochloride Anhydrous

39. Sw199027-2

40. Z0032

41. Ziprasidone Hydrochloride Anhydrous [mi]

42. 939z277

43. A890906

44. Sr-01000759387

45. Sr-01000759387-2

46. Ziprasidone Hydrochloride Anhydrous [who-dd]

47. Q27281411

48. 5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one Hcl

49. 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-2-indolinone Monohydrochloride

50. 5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)-ethyl)-6-chloroindolin-2-one Hydrochloride

51. 5-[2-[4-(1,2-benzisothiazol-3-yl)-1 -piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indol- 2-one Hydrochloride

52. 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1, 3-dihydro-2h-indol-2-one Hydrochloride

53. Ziprasidone Hydrochloride Solution, 1.0 Mg/ml In Methanol, Certified Reference Material, Ampule Of 1 Ml

2.4 Create Date
2005-08-09
3 Chemical and Physical Properties
Molecular Weight 449.4 g/mol
Molecular Formula C21H22Cl2N4OS
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count4
Exact Mass448.0891379 g/mol
Monoisotopic Mass448.0891379 g/mol
Topological Polar Surface Area76.7 Ų
Heavy Atom Count29
Formal Charge0
Complexity573
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameZiprasidone hydrochloride
Drug LabelGEODON is available as capsules (ziprasidone hydrochloride) for oral administration and as an injection (ziprasidone mesylate) for intramuscular use only. Ziprasidone is a psychotropic agent that is chemically unrelated to phenothiazine or butyrophen...
Active IngredientZiprasidone hydrochloride
Dosage FormCapsule
RouteOral
Strengtheq 20mg base; eq 40mg base; eq 80mg base; eq 60mg base
Market StatusPrescription
CompanyMylan Pharms; Wockhardt; Apotex; Lupin Pharms; Sandoz; Dr Reddys Labs

2 of 2  
Drug NameZiprasidone hydrochloride
Drug LabelGEODON is available as capsules (ziprasidone hydrochloride) for oral administration and as an injection (ziprasidone mesylate) for intramuscular use only. Ziprasidone is a psychotropic agent that is chemically unrelated to phenothiazine or butyrophen...
Active IngredientZiprasidone hydrochloride
Dosage FormCapsule
RouteOral
Strengtheq 20mg base; eq 40mg base; eq 80mg base; eq 60mg base
Market StatusPrescription
CompanyMylan Pharms; Wockhardt; Apotex; Lupin Pharms; Sandoz; Dr Reddys Labs

5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Antipsychotic Agents

Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)


Serotonin Antagonists

Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)


Dopamine Antagonists

Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Atypical Antipsychotic [EPC]

API SUPPLIERS

read-more
read-more

01

ChemWerth Inc

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Flag U.S.A
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Chemwerth Compnay Banner

02

LGM Pharma

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
LGM Pharma CB

03

Dr. Reddy's Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WCarrow-down NDC arrow-down KDMF VMF Others AUDIT
Dr Reddy Company Banner

04

Jai Radhe Sales

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJai Radhe Sales is your partner for all your sourcing needs.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Jai Radhe Sales

05

HRV Global Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF AU, MX, ... arrow-down AUDIT
HRV Global Life Sciences

06

Dr. Reddy's Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WCarrow-down NDC arrow-down KDMF VMF Others AUDIT
Dr Reddy Company Banner

07

Wockhardt

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Medlab Asia & Asia Health
Not Confirmed
arrow

Wockhardt

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

08

Raks Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Medlab Asia & Asia Health
Not Confirmed
arrow

Raks Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

09

RANBAXY LABORATORIES LIMITED

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Medlab Asia & Asia Health
Not Confirmed
arrow

RANBAXY LABORATORIES LIMITED

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

10

Qilu Tianhe Pharmaceutical Co., Lt...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Medlab Asia & Asia Health
Not Confirmed
arrow

Qilu Tianhe Pharmaceutical Co., Lt...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Medlab Asia & Asia Health
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-more

01

AES 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 21147

Submission : 2007-12-17

Status : Active

Type : II

Dr Reddy Company Banner

02

AES 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 17922

Submission : 2004-12-23

Status : Active

Type : II

Dr Reddy Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI offers customized CDMO Solutions for API development and manufacturing services.

Flag Israel
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 19005

Submission : 2005-12-07

Status : Inactive

Type : II

TAPI Company Banner

04

Amino Chemicals Ltd

Malta

USDMF

arrow
AES 2024
Not Confirmed

05

Apotex Pharmachem Inc

Canada

USDMF

arrow
AES 2024
Not Confirmed

07

Lupin Ltd

India

USDMF

arrow
AES 2024
Not Confirmed

08

AES 2024
Not Confirmed

10

AES 2024
Not Confirmed

10

AES 2024
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2014-07-07

Pay. Date : 2014-04-04

DMF Number : 20769

Submission : 2007-08-10

Status : Active

Type : II

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1696357800,"product":"PHARMACEUTICAL RAW MATERIAL - ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE USP (COMMERCIAL INVOICE NO:APL\/016\/23-24 & DATE :","address":"PLOT.NO.A-39 & B-11, ROAD.NO.7, IDA KUKATPALLY","city":"HYDERABAD","supplier":"ALMELO","supplierCountry":"INDIA","foreign_port":"ISLAMABAD - ISLAMABA","customer":"TO THE ORDER OF....","customerCountry":"PAKISTAN","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"740","totalValueFC":"3568.5","currency":"USD","unitRateINR":59400,"date":"04-Oct-2023","totalValueINR":"297000","totalValueInUsd":"3568.5","indian_port":"Hyderabad Air","hs_no":"29342000","bill_no":"4391981","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT.NO.A-39 & B-11, ROAD.NO.7, IDA KUKATPALLY, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1703701800,"product":"ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE USP PHARMACEUTICAL RAW MATERIAL(COMMERCIALINVOICE NO:APL\/026\/23-24&DT:20.12.2023)","address":"PLOT.NO.A-39 & B-11, ROAD.NO.7, IDA KUKATPALLY","city":"HYDERABAD","supplier":"ALMELO","supplierCountry":"INDIA","foreign_port":"ISLAMABAD - ISLAMABA","customer":"TO THE ORDER OF....","customerCountry":"PAKISTAN","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"740","totalValueFC":"3579.9","currency":"USD","unitRateINR":59600,"date":"28-Dec-2023","totalValueINR":"298000","totalValueInUsd":"3579.9","indian_port":"Hyderabad Air","hs_no":"29342000","bill_no":"6367919","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT.NO.A-39 & B-11, ROAD.NO.7, IDA KUKATPALLY, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1715711400,"product":"ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE-USP (PHARMACEUTICAL RAW MATERIAL) (COMMERCIAL INV NO:APL\/007\/24-25 & DT:04.05.24)","address":"PLOT.NO.A-39 & B-11, ROAD.NO.7, IDA KUKATPALLY","city":"HYDERABAD","supplier":"ALMELO","supplierCountry":"INDIA","foreign_port":"ISLAMABAD - ISLAMABA","customer":"TO THE ORDER OF....","customerCountry":"PAKISTAN","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"745","totalValueFC":"3391.4","currency":"USD","unitRateINR":56537,"date":"15-May-2024","totalValueINR":"282685","totalValueInUsd":"3391.4","indian_port":"Hyderabad Air","hs_no":"29342000","bill_no":"9890352","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT.NO.A-39 & B-11, ROAD.NO.7, IDA KUKATPALLY, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1725215400,"product":"ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE","address":"Floor No.22, Plot No.1, Survey No.83\/1, Galaxy Tower","city":"Hyderabad","supplier":"APITORIA PHARMA PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"NEW YORK - JOHN F. K","customer":"U.S. PHARMACOPEIA","customerCountry":"UNITED STATES","quantity":"0.37","actualQuantity":"0.37","unit":"KGS","unitRateFc":"40540","totalValueFC":"14707.5","currency":"USD","unitRateINR":3331098.8648648653,"date":"02-Sep-2024","totalValueINR":"1232506.58","totalValueInUsd":"14707.5","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"3679598","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"Floor No.22, Plot No.1, Survey No.83\/1, Galaxy Tower, Hyderabad","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1727375400,"product":"ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE EP","address":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR,H","city":"AHMEDABAD,GUJARAT","supplier":"ZYDUS LIFESCIENCES LIMITED","supplierCountry":"INDIA","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"STADA ARZNEIMITTEL","customerCountry":"GERMANY","quantity":"58.56","actualQuantity":"58.56","unit":"KGS","unitRateFc":"1700","totalValueFC":"107423","currency":"EUR","unitRateINR":153725.70321038249,"date":"27-Sep-2024","totalValueINR":"9002177.18","totalValueInUsd":"107423","indian_port":"Bombay Air","hs_no":"29335990","bill_no":"4371312","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR,H, AHMEDABAD,GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1727634600,"product":"ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE","address":"FLAT NO 101.MATHRUSRI HOMES","city":"HYDERABAD.AP","supplier":"CHROMO LABORATORIES","supplierCountry":"INDIA","foreign_port":"SHEREMETYEVO","customer":"LLC VELPHARM","customerCountry":"RUSSIA","quantity":"6.00","actualQuantity":"6","unit":"KGS","unitRateFc":"83484","totalValueFC":"5868.4","currency":"INR","unitRateINR":81963.128333333341,"date":"30-Sep-2024","totalValueINR":"491778.77","totalValueInUsd":"5868.4","indian_port":"Hyderabad Air","hs_no":"29332990","bill_no":"4456632","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"FLAT NO 101.MATHRUSRI HOMES, HYDERABAD.AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1729881000,"product":"ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE USP(COMMERCIAL INVOICE NO:APL\/033\/24-25 DATE:21.10.2024)","address":"PLOT.NO.A-39 & B-11, ROAD.NO.7, IDA KUKATPALLY","city":"HYDERABAD","supplier":"ALMELO","supplierCountry":"INDIA","foreign_port":"ISLAMABAD - ISLAMABA","customer":"BANK ALFALAH LIMITED ","customerCountry":"PAKISTAN","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"630","totalValueFC":"2715.9","currency":"USD","unitRateINR":45641,"date":"26-Oct-2024","totalValueINR":"228205","totalValueInUsd":"2715.9","indian_port":"Hyderabad Air","hs_no":"29342000","bill_no":"5175811","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT.NO.A-39 & B-11, ROAD.NO.7, IDA KUKATPALLY, HYDERABAD","customerAddress":""}]
04-Oct-2023
26-Oct-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - CAPSULE;ORAL - EQ 20MG BASE

USFDA APPLICATION NUMBER - 20825

read-more

DOSAGE - CAPSULE;ORAL - EQ 40MG BASE

USFDA APPLICATION NUMBER - 20825

read-more

DOSAGE - CAPSULE;ORAL - EQ 60MG BASE

USFDA APPLICATION NUMBER - 20825

read-more

DOSAGE - CAPSULE;ORAL - EQ 80MG BASE

USFDA APPLICATION NUMBER - 20825

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Direct Compression

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Solubilizers

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Granulation

read-more
read-more

Co-Processed Excipients

read-more
read-more

Lubricants & Glidants

read-more
read-more

Coating Systems & Additives

read-more
read-more

Controlled & Modified Release

read-more
read-more

Topical

read-more
read-more

Parenteral

read-more
read-more

Taste Masking

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Empty Capsules

read-more
read-more

Emulsifying Agents

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

API Stability Enhancers

read-more
read-more

Coloring Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Dry Powder Inhalation

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Exclusivities

read-more
read-more

01

arrow
Medlab Asia & Asia Health
Not Confirmed

VIATRIS

U.S.A
arrow
Medlab Asia & Asia Health
Not Confirmed

ZIPRASIDONE HYDROCHLORIDE

Exclusivity Code : M-232

Exclusivity Expiration Date : 2025-01-28

Application Number : 20825

Product Number : 1

Exclusivity Details :

blank

02

arrow
Medlab Asia & Asia Health
Not Confirmed

VIATRIS

U.S.A
arrow
Medlab Asia & Asia Health
Not Confirmed

ZIPRASIDONE HYDROCHLORIDE

Exclusivity Code : M-232

Exclusivity Expiration Date : 2025-01-28

Application Number : 20825

Product Number : 2

Exclusivity Details :

blank

03

arrow
Medlab Asia & Asia Health
Not Confirmed

VIATRIS

U.S.A
arrow
Medlab Asia & Asia Health
Not Confirmed

ZIPRASIDONE HYDROCHLORIDE

Exclusivity Code : M-232

Exclusivity Expiration Date : 2025-01-28

Application Number : 20825

Product Number : 3

Exclusivity Details :

blank

04

arrow
Medlab Asia & Asia Health
Not Confirmed

VIATRIS

U.S.A
arrow
Medlab Asia & Asia Health
Not Confirmed

ZIPRASIDONE HYDROCHLORIDE

Exclusivity Code : M-232

Exclusivity Expiration Date : 2025-01-28

Application Number : 20825

Product Number : 4

Exclusivity Details :

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty